Application of LncRNA RET in regulating and controlling radiosensitivity of tumor cells
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ACADEMY OF MILITARY MEDICAL SCI
- Publication Date
- 2018-12-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biotechnology, in particular to the application of LncRNA RET in regulating radiosensitivity of tumor cells. Background technique
[0002] Genome-wide transcriptome studies have shown that there are a large number of non-coding RNAs (ncRNAs). Non-coding RNAs (non-coding RNAs, ncRNAs) refer to RNA molecules that are not translated into proteins in the transcriptome, including microRNAs (microRNAs, miRNAs), Small nuclear RNA (snRNA), nucleolar small RNA (small nucleolarRNAs, snoRNA), interfering small RNA (small interfering RNA, siRNA), RNA interacting with piwi protein (piwi-interacting RNA, piRNA) etc., long non-coding RNA (long non-codingRNA, LncRNA) and so on. Recent studies estimate that the number of lncRNAs in the human body is about 15,000, and the expression patterns of most lncRNAs are found to be tissue-specific. According to the location and characteristics of LncRNA, it can be divided into five types: ...